Molecular genetics of RB1 - The retinoblastoma gene

Seminars in Ophthalmology

Volumn 22, Issue 4, 2007, Pages 247-254

  Leiderman, Yannek I ^a   Kiss, Szilárd ^a   Mukai, Shizuo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Retinoblastoma; Retinoblastoma gene; Tumor suppressor

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; ETOPOSIDE; RETINOBLASTOMA PROTEIN; VINCRISTINE;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CARCINOGENESIS; CLINICAL FEATURE; CRYOTHERAPY; DNA MODIFICATION; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC CORRELATION; GENOTYPE; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; LEUKOKORIA; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; OPTIC NERVE; PHENOTYPE; PINEAL BODY TUMOR; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; RETINOBLASTOMA; REVIEW; STRABISMUS; TUMOR SUPPRESSOR GENE; VISUAL DISORDER;

GENES, RETINOBLASTOMA; HUMANS; MOLECULAR BIOLOGY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 37549049013     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530701745165     Document Type: Review

References (61)

1. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol 1990; 108(11):1514.
2. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005; 46(8):2683-2691.
3. Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, and Boyd NW, 3rd. Presenting signs of retinoblastoma. J Pediatr 1998; 132(3 Pt 1):505-508.
4. Abramson DH and Schefler AC. Update on retinoblastoma. Retina 2004; 24(6):828-848.
5. Balmer A, Zografos L, and Munier F. Diagnosis and current management of retinoblastoma. Oncogene 2006; 25(38):5341-5349.
6. Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, et al. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 1995; 56(4):887-897.
7. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, and Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391(6667):597-601.
8. Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostachfi H, et al. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet, 1997; 61(3):556-570.
9. Chan HS, Gallie BL, Munier FL, and Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am 2005; 18(1):55-63, viii.
10. Chen PL, Scully P, Shew JY, Wang JY, and Lee WH Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58(6):1193-1198.
11. Chow KN, and Dean DC. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 1996; 16(9):4862-4868.
12. Connolly MJ, Payne RH, Johnson G, Gallie BL, Allderdice PW, Marshall WH, et al. Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 1983; 65(2):122-124.
13. De Falco G, & Giordano A. pRb2/p130: a new candidate for retinoblastoma tumor formation. Oncogene 2006; 25(38):5333-5340.
14. de Jong PT, Mooy CM, Stoter G, Eijkenboom WM, & Luyten GP. Lateonset retinoblastoma in a well-functioning fellow eye. Ophthalmology 2006; 113(6):1040-1044.
15. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54(2):275-283.
16. Draper GJ, Sanders BM, & Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986; 53(5):661-671.
17. Dryja TP, Rapaport J, McGee TL, Nork TM, & Schwartz TL. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 1993; 52(6):1122-1128.
18. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12(15):2245-2262.
19. Dyson N, Howley PM, Munger K, & Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243(4893):934-937.
20. Flemington EK, Speck SH, & Kaelin WG, Jr. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A 1993; 90(15):6914-6918.
21. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323(6089):643-646.
22. Frischmeyer PA, & Dietz HC Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999; 8(10):1893-1900.
23. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, & Benedict WF. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236(4809):1657-1661.
24. Harbour JW, & Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000; 2(4):E65-67.
25. Helin K, Harlow E, & Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993; 13(10):6501-6508.
26. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107(8):1711-1742.
27. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol, 1999; 17(6):1829-1837.
28. Klutz M, Brockmann D, & Lohmann DR. A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene. Am J Hum Genet 2002; 71(1):174-179.
29. Klutz M, Horsthemke B, & Lohmann DR. RB1 gene mutations in peripheral blood DNA of patients with isolated unilateral retinoblastoma. Am J Hum Genet 1999; 64(2):667-668.
30. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68(4):820-823.
31. Lee JO, Russo AA, & Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998; 391(6670):859-865.
32. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, & Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987; 235(4794):1394-1399.
33. Lee WH, Murphree AL, & Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature, 1984; 309(5967):458-460.
34. Lohmann DR. RB1 gene mutations in retinoblastoma. Hum Mutat 1999; 14(4):283-288.
35. Lohmann DR, & Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 2004; 129(1):23-28.
36. Lohmann DR, Gerick M, Brandt B, Oelschlager U, Lorenz B, Passarge E, et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet 1997; 61(2):282-294.
37. Luo RX, Postigo AA, & Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998; 92(4):463-473.
38. Macklin MT. A study of retinoblastoma in Ohio. Am J Hum Genet, 1960; 12:1-43.
39. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998; 391(6667):601-605.
40. Mahoney MC, Burnett WS, Majerovics A, & Tanenbaum H. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology 1990; 97(9):1143-1147.
41. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001; 412(6846):561-565.
42. Otterson GA, Chen W, Coxon AB, Khleif SN, & Kaye FJ. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proc Natl Acad Sci U S A 1997; 94(22):12036-12040.
43. Palazzi M, Abramson DH, & Ellsworth RM. Endophytic vs exophytic unilateral retinoblastoma: is there any real difference? J Pediatr Ophthalmol Strabismus 1990; 27(5):255-258.
44. Schultz KR, Ranade S, Neglia JP, & Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer 1993; 72(1):282-286.
45. Sellers WR, Rodgers JW, & Kaelin WG, Jr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci U S A 1995; 92(25):11544-11548.
46. Shen WJ, Kim HS, & Tsai SY. Stimulation of human insulin receptor gene expression by retinoblastoma gene product. J Biol Chem 1995; 270(35):20525-20529.
47. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, & Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 2002; 120(12):1653-1658.
48. Shields CL, & Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol, 2006; 17(3):228-234.
49. Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997; 104(12):2101-2111.
50. Shields JA, Parsons HM, Shields CL, & Shah P. Lesions simulating retinoblastoma. J Pediatr Ophthalmol Strabismus 1991; 28(6):338-340.
51. Shimizu T, Toguchida J, Kato MV, Kaneko A, Ishizaki K, & Sasaki MS. Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Am J Hum Genet 1994; 54(5):793-800.
52. Sippel KC, Fraioli RE, Smith GD, Schalkoff ME, Sutherland J, Gallie BL, et al. Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet 1998; 62(3):610-619.
53. Stein GH, Beeson M, & Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990; 249(4969):666-669.
54. Strong LC, Riccardi VM, Ferrell RE, & Sparkes RS. Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science 1981; 213(4515):1501-1503.
55. Suckling RD, Fitzgerald PH, Stewart J, & Wells E. The incidence and epidemiology of retinoblastoma in New Zealand: A 30-year survey. Br J Cancer 1982; 46(5):729-736.
56. Tamboli A, Podgor MJ, & Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990; 108(1):128-132.
57. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993; 17(3):535-543.
58. Walton DS, Mukai S, Grabowski EF, Munzenrider JE, & Dryja TP. Case records of the Massachusetts General Hospital. Case 5-2006. An 11-year-old girl with loss of vision in the right eye. N Engl J Med 2006; 354(7):741-748.
59. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, & Dean DC. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 1995; 375(6534):812-815.
60. Whitaker LL, Su H, Baskaran R, Knudsen ES, & Wang JY. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol Cell Biol 1998; 18(7):4032-4042.
61. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334(6178):124-129.